Sensus Healthcare

Sensus Healthcare is a publicly traded medical device company specializing in non-invasive superficial radiation therapy (SRT) for the treatment of non-melanoma skin cancers (basal cell carcinoma and squamous cell carcinoma) and keloids. The company manufactures a portfolio of proprietary low-energy X-ray SRT devices designed for use in dermatology offices and healthcare systems. The product line includes the SRT-100™, SRT-100+™, and SRT-100 Vision™—compact, office-based systems that deliver precise, calibrated doses of superficial radiotherapy without the need for surgery, anesthesia, or significant downtime. SRT technology provides an effective alternative to traditional surgical interventions, with minimal risk of infection or scarring. All devices are covered by Medicare and major insurers. Sensus Healthcare emphasizes patient-centric care, ethical practices, multidisciplinary collaboration, and continuous innovation in dermatological oncology.